Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Edwards Lifesciences
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the CardiAQ-Edwards™ Transcatheter Mitral Valve with transapical and transseptal delivery systems in patients with degenerative or functional/ischemic mitral regurgitation.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
NYHA ≥ II
Moderate/severe or severe mitral regurgitation
Prohibitive risk for open-heart surgery
Meets anatomical criteria
You may not be if
Unsuitable anatomy
Need for emergent or urgent surgery
Prior mechanical aortic valve replacement
Any prior surgical or transcatheter repair (excluding balloon valvuloplasty) or replacement of the mitral valve
